Working group on “Value of Diagnosis” discusses survey results
Tuesday 29 March 2011
Representatives of the working group for the AE project on the “Value of diagnosis” met in Toronto, Canada in the framework of the ADI Conference whilst other members joined the meeting via teleconference.
The meeting allowed the working group to discuss the top line results of the public opinion survey that was carried out by TNS in France, Germany, Poland, Spain and the US. In each country, 500 telephone interviews (640 for the US) were conducted to ascertain the general public’s:
- perceptions of Alzheimer’s disease,
- knowledge and experience about Alzheimer’s disease and
- views on the value of a diagnosis of Alzheimer’s disease.
The highly interesting results were discussed by the participants and a report on the key results will now be developed by the Harvard School of Public Health and the members of the working group. The results and report will be launched at the ICAD Conference in Paris.
Alzheimer Europe gratefully acknowledges the support it has received from Bayer Healthcare for this project and survey.